Withdrawal Policy
Medvix Publications strongly discourages the withdrawal or removal of articles. Submissions and withdrawals of manuscripts are in the interest of the author. However, withdrawal of the manuscript should only be exercised for rare and unavoidable reasons. A withdrawal would mean wasting the time and effort spent processing the manuscript for its validity by the editors, reviewers, and other editorial staff.
There will be no cost for withdrawals requested within 48 hours.
If the withdrawal is requested after the peer review, in the publication phase, or after the manuscript is published online, 50% of the total invoice value will be applied.
It is advised to all authors that they be sure of the article’s validity, genuineness, and error-free nature. A fresh submission after withdrawal will mean a fresh start and attract the regular article processing fee.
Removal, deletion, or obscuring of the article or part of it will be allowed only in the following circumstances:
- Legal infringements
- Defamation
- Other legal limitations
- False or inaccurate data – especially those that, if acted upon, could pose a health risk
Notice of Withdrawal
Articles withdrawn by either the author or the publisher will need to accompany a notice explaining the circumstances for the withdrawal or rejection.
Articles in press (articles accepted for publication or published as e-pub ahead of schedule but not formally published with volume/issue/page information) that contain errors or violate the publishing ethics guidelines (such as multiple submissions, fake claims of authorship, plagiarism, fraudulent use of data) may be “withdrawn” from the journal. Withdrawal means that the article files are removed and replaced with a PDF, and the article is marked as withdrawn according to Medvix's editorial policies.
Article Retraction
Published articles that may violate professional and ethical standards (such as multiple submissions, false claims of authorship, plagiarism, or fraudulent data usage) will be retracted. Medvix Publications adheres to Cope’s guidelines for retraction.
Redundant (Multiple) Publication / Re-publication
Medvix Publications editors have specific guidelines regarding abstracts and posters presented at conferences. Any content shared at meetings aimed at informing participants, as well as data displayed in databases (including data without interpretation, discussion, context, or conclusions presented in both tables and descriptive text), are not considered prior publications. Authors looking to publish translations of articles previously published elsewhere must obtain the necessary permissions, clearly indicate that the material has been translated and republished, and provide the source of the original content.